A group of experts discuss new and emerging therapies for IBD.
A group of experts from the University of North Carolina at Chapel Hill have come together to discuss many crucial topics for the treatment of patients with inflammatory bowel disease (IBD).
The panel was part of HCPLive’s® State of the Science Summit called Institutional Perspectives in Gastroenterology: Inflammatory Bowel Disease.
Leading the group was Millie Long, MD, MPH. Joining Long was Kimberly Weaver, MD, Edward Barnes, MD, MPH, and Hans Herfarth, MD, PhD.
The program began with Weaver’s discussion on managing IBD during COVID-19. Weaver’s discussion was followed by Barnes talking about the early use of biologics and Herfarth’s explainer on newly approved and emerging therapies in IBD.
Long closed out the event with a talk about taking a treat to target approach in IBD.